Association of lenvatinib plasma concentration with clinical efficacy and adverse events in patients with hepatocellular carcinoma
Kojiro Hata, Kimitaka Suetsugu, Nobuaki Egashira, Yoko Makihara, Shinji Itoh, Tomoharu Yoshizumi, Masatake Tanaka, Motoyuki Kohjima, Hiroyuki Watanabe, Satohiro Masuda, Ichiro Ieiri
Topics & Concepts
MedicineInternal medicineCommon Terminology Criteria for Adverse EventsLenvatinibAdverse effectHepatocellular carcinomaGastroenterologyConfidence intervalResponse Evaluation Criteria in Solid TumorsOncologyProgressive diseaseSorafenibDiseaseHepatocellular Carcinoma Treatment and PrognosisColorectal Cancer Treatments and StudiesHER2/EGFR in Cancer Research